Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

260
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
260
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

418
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
418
Depression: Overview01:18

Depression: Overview

263
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
263
Long-term Depression01:05

Long-term Depression

30.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.9K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

50
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
50
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

150
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
150

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The longer, the better? Investigating the effect of prolonged acoustic stimulation on brief acoustic tinnitus suppression.

BMC neurology·2026
Same author

Trajectory of COVID-related tinnitus over the pandemic timeline.

Brazilian journal of otorhinolaryngology·2026
Same author

Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trial.

Communications medicine·2026
Same author

Tinnitus and tinnitus disorder: Genetic, neurobiological, and clinical differentiation.

iScience·2026
Same author

Sound hypersensitivity phenotypes and sound hypersensitivity disorder.

Neuroscience and biobehavioral reviews·2026
Same author

E-field guided repetitive transcranial magnetic stimulation modulates oscillatory brain activity dynamics in tinnitus.

Brain research bulletin·2026

Related Experiment Video

Updated: Jul 14, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K

Tinnitus and treatment-resistant depression.

Berthold Langguth1, An-Suey Shiao2, Jen-Tsung Lai3

  • 1Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.

Progress in Brain Research
|October 8, 2023
PubMed
Summary

Tinnitus is the perception of phantom sound, with Tinnitus Disorder impacting 2-3% of people. Addressing comorbidities like depression is crucial for managing tinnitus distress, as causal treatments are unavailable.

Keywords:
DepressionMagnetoencephalography (MEG)TinnitusTinnitus disorderTreatment resistant depression (TRD)

More Related Videos

A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
07:05

A Protocol for the Administration of Real-Time fMRI Neurofeedback Training

Published on: August 24, 2017

11.1K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.6K

Related Experiment Videos

Last Updated: Jul 14, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K
A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
07:05

A Protocol for the Administration of Real-Time fMRI Neurofeedback Training

Published on: August 24, 2017

11.1K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.6K

Area of Science:

  • Neuroscience
  • Otolaryngology
  • Psychiatry

Background:

  • Tinnitus is the perception of phantom sound, affecting a significant portion of the population.
  • A distinction is made between tinnitus (auditory component) and Tinnitus Disorder (auditory component plus suffering).
  • High tinnitus burden is linked to comorbidities, notably depression.

Conclusions:

  • Identifying and treating comorbidities, particularly depression and TRD, is vital for reducing tinnitus-related suffering.
  • Understanding the link between tinnitus and depression is essential for comprehensive patient care.
  • Further research into the relationship between tinnitus and treatment-resistant depression is warranted.